Form 4 for INSP Inspire Medical Systems, Inc.
Accepted 2021-12-28 00:00:00 ET · period of report 2021-12-23 · accession 0001104659-21-153990 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-12-28 | 2021-12-23+ | INSP | Ban Randy | Chief Commercial Off | S - Sale+OE | $240.00 | -9,760 | 248 | -98% | -$2.34M |
| DM | 2021-12-28 | 2021-12-23+ | INSP | Ban Randy | Chief Commercial Off | M - OptEx | $1.35 | +9,760 | 894 | New | +$13.1K |
| DM | 2021-12-28 | 2021-12-23+ | INSP | Ban Randy | Chief Commercial Off | M - OptEx | $0.00 | -9,760 | 8,567 | -53% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-12-27 | S | D | 1,418 | $240.00 | 248 | D | — | — | |
| 2 | Common | Common Stock | 2021-12-27 | M | A | 772 | $0.94 | 1,666 | D | — | — | |
| 3 | Common | Common Stock | 2021-12-23 | S | D | 8,342 | $240.00 | 248 | D | — | — | |
| 4 | Common | Common Stock | 2021-12-23 | M | A | 5,488 | $0.94 | 8,590 | D | — | — | |
| 5 | Common | Common Stock | 2021-12-23 | M | A | 2,854 | $2.07 | 3,102 | D | — | — | (F1) Includes 19 additional shares acquired under the Inspire Medical Systems, Inc. 2018 Employee Stock Purchase Plan since the Reporting Person's ownership report filed on January 6, 2021. |
| 6 | Common | Common Stock | 2021-12-27 | M | A | 646 | $2.07 | 894 | D | — | — | |
| 7 | Derivative | Stock Option (Right to Buy) | 2021-12-23 | M | D | 5,488 | $0.00 | 8,045 | D | $0.94 · — to 2027-01-01 | 5,488 Common Stock | (F3) The option is fully vested and exercisable. (F4) This option grant was previously reported as having an expiration date of December 31, 2026, which has been revised herein. |
| 8 | Derivative | Stock Option (Right to Buy) | 2021-12-23 | M | D | 2,854 | $0.00 | 9,213 | D | $2.07 · — to 2024-03-31 | 2,854 Common Stock | (F3) The option is fully vested and exercisable. |
| 9 | Derivative | Stock Option (Right to Buy) | 2021-12-27 | M | D | 772 | $0.00 | 7,273 | D | $0.94 · — to 2027-01-01 | 772 Common Stock | (F3) The option is fully vested and exercisable. |
| 10 | Derivative | Stock Option (Right to Buy) | 2021-12-27 | M | D | 646 | $0.00 | 8,567 | D | $2.07 · — to 2024-03-31 | 646 Common Stock | (F3) The option is fully vested and exercisable. |